Peptide World
EN
← Research Library
Longevity · 5 min read Evidence: Human pilot

GHK-Cu: the copper peptide behind the skincare claims

A three-residue peptide from human plasma that binds copper. Lab data are broad; human data are mostly cosmetic.

What it is

GHK (glycyl-histidyl-lysine) is a tripeptide first identified in human plasma. It binds copper ions tightly, forming GHK-Cu. Levels are reported to fall with age, which is part of why it attracts longevity interest.

What lab studies suggest

Cell and animal studies link GHK-Cu to wound healing, collagen production and antioxidant activity. Analyses of gene-expression databases suggest it may influence many genes involved in tissue repair. These analyses generate hypotheses; they don’t show what happens in a person.

What human studies show

Human data come mainly from small studies of topical skincare products. That’s why GHK-Cu is common as a cosmetic ingredient — and why claims about injected or systemic use run far ahead of the evidence.

Bottom line

Evidence ladder: Human pilot (topical, cosmetic). Not an approved drug.

Sources

  1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci 2018 ↗

Questions about this article? The AI Scholar can walk you through the studies.

Educational content only — not medical advice. See our Medical disclaimer and Editorial policy.

Keep reading